ITGAM and neoplasm: Data from the B16-F10 and CT26 syngeneic tumor models have shown that mice with delayed-growth tumors elicited significantly higher numbers of cross-presenting TAM, phenotypically characterized by CD11b+F4/80hiCD206+, compared with mice with rapid-growth tumors (Figure 2 and Supplemental Figure 3).